• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.56% Nasdaq Down0.79%

    Boston Scientific Corporation (BSX)

    21.81 Up 0.03(0.14%) 4:01PM EDT
    |After Hours : 21.81 0.00 (0.00%) 4:41PM EDT
    ProfileGet Profile for:
    Boston Scientific Corporation
    300 Boston Scientific Way
    Marlborough, MA 01752
    United States - Map
    Phone: 508-683-4000
    Website: http://www.bostonscientific.com

    Index Membership:N/A
    Industry:Medical Appliances & Equipment
    Full Time Employees:25,000

    Business Summary 

    Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: Cardiovascular, Rhythm Management, and MedSurg. The company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; coronary technology products to treat atherosclerosis; intraluminal catheter-directed ultrasound imaging catheters and systems for use in coronary arteries and heart chambers, as well as peripheral vessels; and structural heart therapy systems. It also provides stents, balloon catheters, wires, peripheral embolization devices, and vena cava filters used to treat peripheral disease; and biliary stents, drainage catheters, and micro-puncture sets to treat, diagnose, and ease benign and malignant tumors. In addition, the company offers cardiac rhythm management devices, such as implantable cardioverter defibrillator systems to detect and treat abnormally fast heart rhythms; implantable cardiac resynchronization therapy pacemaker systems used to treat heart failure; and medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising steerable radio frequency ablation catheters, intracardiac ultrasound catheters, diagnostic catheters, delivery sheaths, and other accessories. Further, it provides products to treat diseases of the pulmonary and gastrointestinal conditions; devices to diagnose, treat, and ease pulmonary disease systems within the airway and lungs; products to treat urinary stone disease and benign prostatic hyperplasia; mid-urethral sling products, sling and graft materials, pelvic floor reconstruction kits, and suturing devices; and spinal cord stimulator systems. The company was founded in 1979 and is headquartered in Marlborough, Massachusetts.

    Key Statistics

    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Boston Scientific Corporation

    Corporate Governance 
    Boston Scientific Corporation’s ISS Governance QuickScore as of May 1, 2016 is 8. The pillar scores are Audit: 2; Board: 9; Shareholder Rights: 9; Compensation: 3.
    Brought to you by Institutional Shareholder Services (ISS)

    Key Executives 
    Mr. Peter Michael Nicholas , 74
    Co-Founder and Chairman
    Mr. Michael F. Mahoney , 51
    Chief Exec. Officer, Pres and Director
    Mr. Daniel J. Brennan , 50
    Chief Financial Officer and Exec. VP
    Mr. Timothy A. Pratt , 66
    Chief Admin. Officer, Exec. VP, Gen. Counsel and Sec.
    Mr. Joseph M. Fitzgerald , 52
    Exec. VP and Pres of Rhythm Management
    Amounts are as of Dec 31, 2015 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders